Alucent Biomedical, Inc. — Form D

Alucent Biomedical, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-20. The offering totals $11.2M, of which $11.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
James CorbettDirectorSalt Lake City, UT
David FlicekDirectorSalt Lake City, UT
Myles GreenbergDirectorSalt Lake City, UT
Julie LauttDirectorSalt Lake City, UT
Nick PappasDirectorSalt Lake City, UT
Daniel PelakDirectorAliso Viejo, CA
Myles GreenbergExecutive OfficerSalt Lake City, UT
Henry HauserExecutive OfficerSalt Lake City, UT
James IsaacsonExecutive OfficerSalt Lake City, UT
Colin JacksonExecutive OfficerSalt Lake City, UT
Katalin KauserExecutive OfficerSalt Lake City, UT
Bruce KrattenmakerExecutive OfficerSalt Lake City, UT
Kevin WarnerExecutive OfficerSalt Lake City, UT
Dan D PelakDirectorSalt Lake City, UT
David N FlicekDirectorSalt Lake City, UT
Myles D GreenbergDirectorSalt Lake City, UT
Myles D GreenbergExecutive OfficerSalt Lake City, UT
James D CorbettDirectorSalt Lake City, UT
Scott N MayfieldExecutive OfficerSalt Lake City, UT
Ryan D HansenDirectorSalt Lake City, UT
Pat D CostelloDirectorSalt Lake City, UT
Julie N LauttDirectorSalt Lake City, UT
Michael ElliotDirectorAustin, TX
Julie NortonDirectorSioux Falls, SD
David KapaskaDirectorSioux Falls, SD

Other filings by this issuer (2)

FiledFormOfferingSold
2020-10-15D$35.0M$35.0M
2015-01-27D$400K$400K

More